Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: L. C. M. Ltd., Linthwaite Laboratories, Huddersfield, HD7 5QH
Sensitivity to Eucalyptus Oil.
Not recommended for infants under 1 year.
Keep all medicines out of the reach and sight of children.
Not to be take orally.
If symptoms persist consult your doctor.
None known.
No evidence can be found as to the safety of the product in pregnancy or lactation. The use of all drugs should be avoided during the first trimester.
At the dosage indicated, no evidence can be found that the product affects the ability to drive or to use machinery.
When used as a rubefacient it may induce skin sensitisation and eczema.
No adverse effects of inhalation are reported but in sensitised individuals the precipitation of hay fever or asthma are potential unwanted effects.
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
None known.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
